# LUXTURNA

NDC: 71394-415
Generic name: voretigene neparvovec-rzyl
Labeler / Manufacturer: Spark Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20171219

FDA application: BLA125610

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71394-415"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71394-415
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=08313a24-e7ce-457a-bb3f-161bc45517ee
